MEGAN SHIROMA: Open Payments
NPI 1841736386 · CERRITOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,476 in 129 payments from 17 companies in 2025. Trend: 2023 $2,750 · 2024 $3,420 · 2025 $3,476
Food & beverage: $3,319Education: $157
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 22 | $905 |
| ABBVIE INC. | 45 | $798 |
| Janssen Biotech, Inc. | 9 | $546 |
| Novartis Pharmaceuticals Corporation | 17 | $232 |
| UCB, Inc. | 8 | $196 |
| AstraZeneca Pharmaceuticals LP | 3 | $129 |
| GENZYME CORPORATION | 1 | $116 |
| ANI Pharmaceuticals, Inc. | 4 | $111 |
| Radius Health, Inc. | 3 | $94 |
| E.R. Squibb & Sons, L.L.C. | 3 | $70 |
Products named: TREMFYA, RINVOQ, TAVNEOS, SKYRIZI, COSENTYX, KRYSTEXXA, Bimzelx, OTEZLA.
Industry payments across CA — which companies pay providers there.
